International product information

The product details shown after you switch describe the versions of Rho authorized outside the United States, including the Rho Score, which is not part of the US version.

US product information

The product details shown after you switch describe the version of Rho authorized in the United States, which reports whether a patient is Rho Positive.

Request a demo →
← All news
Deployments and partnerships

CAN Health Network announces Rho project at Sunnybrook

Toronto. The CAN Health Network, which introduces Canadian health technologies into the health system, announced its commercialization project evaluating Rho at Sunnybrook Health Sciences Centre. In the first month, Rho screened 567 patients and flagged 370 for possible low bone density.

The project brought Rho to Sunnybrook, one of Canada’s largest academic hospitals, for a prospective study of opportunistic screening for low bone density in clinical use. It was 16 Bit’s first hospital deployment through the CAN Health Network.

Dr. Dante Morra, Chair of the CAN Health Network, welcomed the work between Sunnybrook and 16 Bit in the announcement.

The deployment became the setting for a prospective study of Rho in clinical use, published in the Canadian Association of Radiologists Journal in 2025, and the project received the Network’s 2023 Impact Award.